Repositioning Quinacrine Toward Treatment of Ovarian Cancer by Rational Combination With TRAIL-Reference-Cited by-同舟云学术

Repositioning Quinacrine Toward Treatment of Ovarian Cancer by Rational Combination With TRAIL

Published:2020-07-16 Issue: Volume:10 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Liang Rui,Yao Yuanfei,Wang Guangyu,Yue Er,Yang Guangchao,Qi Xiuying,Wang Yang,Zhao Ling,Zheng Tongsen,Zhang Yanqiao,Wenge Wang Edward

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference55 articles.

1. Targeting the extrinsic apoptotic pathway in cancer: lessons learned and future directions;Ashkenazi;J Clin Invest.,2015

2. Dulanermin in indolent lymphomas: an ineffective approach;Arcaini;Lancet Haematol.,2015

3. Identification and characterization of a new member of the TNF family that induces apoptosis;Wiley;Immunity.,1995

4. Preclinical studies to predict the disposition of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand in humans: characterization of in vivo efficacy, pharmacokinetics, and safety;Kelley;J Pharmacol Exp Ther.,2001

5. Ligand-based targeting of apoptosis in cancer: the potential of recombinant human apoptosis ligand 2/tumor necrosis factor–related apoptosis-inducing ligand (rhApo2L/TRAIL);Ashkenazi;J Clin Oncol.,2008

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Repurposing antiparasitic drugs for the treatment of other diseases;Advances in Antiparasitic Therapies and Drug Delivery;2024

2. Low doses of niclosamide and quinacrine combination yields synergistic effect in melanoma via activating autophagy-mediated p53-dependent apoptosis;Translational Oncology;2022-07

3. Repurposing of Anti-Malarial Drug Quinacrine for Cancer Treatment: A Review;Scientia Pharmaceutica;2022-02-08

4. Quinacrine binds to the kinase domain of FGFR1 and inhibits its activity;2021-12-02

5. First-in-Human Phase 1b Trial of Quinacrine Plus Capecitabine in Patients With Refractory Metastatic Colorectal Cancer;Clinical Colorectal Cancer;2021-03